The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer

Oncogene

Volumn 14, Issue 5, 1997, Pages 561-568

  Chang, Joe Yujiao ^a   Xia, Weiya ^a   Shao, Ruping ^a   Sorgi, Frank ^c   Hortobagyi, Gabriel N ^b   Huang, Leaf ^c   Hung, Mien Chie ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adenoviral vector; Cationic liposome; E1A; Gene therapy; HER 2 neu

Indexed keywords

LIPOSOME; VIRUS PROTEIN;

ADENOVIRUS 5; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FRAMESHIFT MUTATION; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS TYPE 5;

EID: 0031046455     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1200861     Document Type: Article

References (38)

1. Bargmann CI, Huang MC and Weinber RA. (1986). Nature, 319, 226-230.
2. Baselga J, Tripathy D, Mendelsohn J, Baughman S and Benz CC. (1996). J. Clin. Oncol., 14, 737-744.
3. Berchuck A, Kamel A, Whitake R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks P, McKenzie S, Yin S and Bast RC. (1990). Cancer Res., 50, 4087-4091.
4. Borg A, Tandon AK, Sigurdfsson H, Clark GM, Ferno M, Fuqua SAW, Killander D and McGuire WL. (1990). Cancer Res., 50, 4332-4337.
5. Bouchard L, Lamarre L, Tremblay PJ and Jolicoeur P. (1989). Cell, 57, 931-936.
6. Chang JY, Xia W, Shao R and Hung MC. (1996). Oncogene, (in press).
7. Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levinson UFA and Ullrich A. (1985). Science, 230, 1132-1139.
8. Gao X and Huang L. (1991). Biochem. Biophys. Res. Commun., 179, 280-285.
9. Guy CT, Webster MA, Schaller L, Parsons TJ, Cardiff RD and Muller WJ. (1992). Proc. Natl. Acad. Sci. USA, 89, 10578-10582.
10. Harris JR, Morrow M and Bonadonna G. (1993). Cancer: Principles and practice of oncology. Devita VT Jr, Hellman S and Rosenberg SA (eds). J.B. Lippencott Co.: Philadelphia, pp. 1264-1332.
11. Hearing P and Shenk T. (1985). Mol. Cell. Biol., 5, 3214-3221.
12. Hung MC, Matin A, Zhang YJ, Xing X, Sorgi F, Huang L and Yu D. (1995). Gene, 159, 65-71.
13. Kallioniemi OP, Holli K, Visakorpi T, Koivula T, Helin HH and Isola JJ. (1991). Int. J. Cancer, 49, 650-655.
14. Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Greene MI, Torney L and Robinson RA. (1990). Cancer Res., 50, 5284-5191.
15. Knowles MR, Hohnker KW, Zhou Z, Olsen JC and Noah TL. (1995). New Eng. J. Med., 333, 823-831.
16. Lowe SW, Ruley HE, Jack T and Housman DE. (1993). Cell, 74, 957-967.
17. Muller WJ, Snn E, Pattengale PK, Wallace R and Leder P. (1988). Cell, 54, 105-115.
18. Nabel G, Nabel EG, Yang Z, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D and Chang AE. (1993). Proc. Natl. Acad. Sci. USA, 90, 11307-11311.
19. Parker SE, Vahlsing HE, Serfilippi LM, Franklin CL and Doh SG. (1995). Human Gene Therapy, 6, 575-590.
20. Paterson MC, Dietrich KD, Danyluk J, Paterson AHG, Lees AW, Jamil N, Hanson J, Jenkins H, Krause BE, McBlain WA, Slamon DJ and Fourney RM. (1991). Cancer Res., 51, 556-567.
21. Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz JD, Godolphin W, Sliwkowski M, Akita R, Paterson MC and Slamon D. (1993). Cancer Res., 53, 5675-5682.
22. Rao L, Debbas M, Sabbatini P, Hocknbery D, Korsmeyer S and White E. (1992). Proc. Natl. Sci. Acad. USA, 89, 7742-7746.
23. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 23, 177-182.
24. Simon RH, Engelhardt JF, Yang Y, Zepeda M, Weber-Pendleton S, Grossman M and Wilson JM. (1993). Human Gene Therapy, 4, 771-780.
25. Teodoro JG, Shore GC and Branton PE. (1995). Oncogene, 11, 467-474.
26. Tsai CM, Chang KT, Perng RP, Mitsudomi T, Chen MH and Gazdar AF. (1993). J. Natl. Cancer Inst., 85, 897-901.
27. Tsai CM, Yu D, Chang KT, Wu LH, Perng RP, Ibrahim NK and Hung MC. (1995). J. Natl. Cancer Inst., 87, 682-684.
28. Yamamoto T, Ikawa S, Akiyama KS, Nomura N, Miyajima N, Saito T and Toyoshima K. (1986). Nature, 319, 230-232.
29. Yan DH, Chang LS and Hung MC. (1991). Oncogens, 6, 343-345.
30. Yonemura Y, Ninoomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, Miyazaki I, Endou Y, Tanaka PM and Sasaki T. (1991). Cancer Res., 51, 1034-1038.
31. Yu D and Hung MC. (1991). Oncogene, 6, 1991-1996.
32. Yu D, Wang SS, Dulski KM, Tsai CM, Nicolson GL and Hung MC. (1994). Cancer Res., 54, 3260-3266.
33. Yu D, Scorsone K and Hung MC. (1991). Mol. Cell. Biol., 11, 1745-1750.
34. Yu D, Suen TC, Yan DH, Chang LS and Hung MC. (1990). Proc. Natl. Acad. Sci. USA, 87, 4499-4503.
35. Yu D, Hamada JI, Zhang H, Nicolson GL and Hung MC. (1992). Oncogene, 7, 2263-2270.
36. Yu D, Shi D, Scanion M and Hung MC. (1993). Cancer Res., 53, 5784-5790.
37. Yu D, Matin A, Xia W, Sorgi F, Huang L and Hung MC. (1995). Oncogene, 11, 1383-1388.
38. Zhang YJ, Yu DH, Xia WY and Hung MC. (1995). Oncogene, 10, 1947-1954.